Cargando…
Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial
OBJECTIVE: Women with pre‐eclampsia have elevated circulating levels of soluble fms‐like tyrosine kinase‐1 (sFlt‐1). Statins can reduce sFlt‐1 from cultured cells and improve pregnancy outcome in animals with a pre‐eclampsia‐like syndrome. We investigated the effect of pravastatin on plasma sFlt‐1 l...
Autores principales: | Ahmed, A, Williams, DJ, Cheed, V, Middleton, LJ, Ahmad, S, Wang, K, Vince, AT, Hewett, P, Spencer, K, Khan, KS, Daniels, JP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063986/ https://www.ncbi.nlm.nih.gov/pubmed/31715077 http://dx.doi.org/10.1111/1471-0528.16013 |
Ejemplares similares
-
The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years
Publicado: (2007) -
The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months
Publicado: (2007) -
Placental growth factor testing for suspected pre‐eclampsia: a cost‐effectiveness analysis
por: Duhig, KE, et al.
Publicado: (2019) -
Glycosylated fibronectin point‐of‐care test for diagnosis of pre‐eclampsia in a low‐resource setting: a prospective Southeast Asian population study
por: Nagalla, SR, et al.
Publicado: (2020) -
Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial
por: Tajik, P, et al.
Publicado: (2012)